Microbiology & Virology Market Research Reports & Industry Analysis
One of the main focuses in virology is the study of viral infectious diseases including: rhinoviruses (common cold), influenza (flu), Herpes (simplex, zoster and varicella-zoster), AIDS (autoimmune deficiency virus), Human Papillomavirus (HPV), rabies and measles.
Some viruses, known as oncoviruses, are known to be cancer causing. The most widely studied example is the link between HPV, a sexually transmitted virus, and cervical cancer.
There are more then 150 strains of HPV, over 40 of which are sexually transmitted. Certain types of “high-risk” sexually transmitted HPV viruses can lead to cell mutations and cause cervical cancer as well as cancer of the vagina, vulva, penis and anus. Research shows that these high-risk HPV viruses cause over 99% of cervical cancers.
According to the National Cancer Institute, it is estimated that in 2010 about 12,000 women in the United States were diagnosed with cervical cancer and more than 4000 would die from it.
Although there are no treatments available for HPV, the FDA approved Cervarix and Gardisil, vaccines used to protect against the types of HPV that most commonly cause cervical cancer.
Microbiology & Virology Industry Research & Market Reports
-
Global Cervical Cancer Treatment Market - 2022-2029
... cervix is the lower part of the uterus that connects to the vagina. Cervical cancer begins in the cells of the cervix. Most cervical malignancies are caused by strains of the sexually transmitted pathogen, Human ... Read More
-
Global Legionella Testing Market - 2022-2029
... pneumonia called Legionnaires disease or flu-like illness. Legionella testing aids in detecting the presence of bacteria to help diagnose the cause of a person's pneumonia. Market Dynamics The major driving forces are the rising incidence ... Read More
-
Global Clinical Microbiology Market - 2022-2029
... 6.5% during the forecast period (2022-2029). Clinical microbiology focuses on all aspects of patient infections from testing samples to identifying bacterial, viral, fungal, and parasitic agents that are contributing to the infectious process, determining the ... Read More
-
Mycobacterium Tuberculosis Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
... Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update provides comprehensive information about the Mycobacterium Tuberculosis Tests pipeline products with comparative analysis of the products at various stages of development and information about ... Read More
-
Point-of-Care Diagnostics Market Size, Share, Trends, Analysis and Forecast by Region, Segment, Product (Glucose Monitoring Products, Infectious Disease Testing Products) and Platform (Lateral Flow Assays, Immunoassays), 2022-2027
... at US$36.99 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 11.92% during 2022-2027. The point-of-care diagnostics market report provides an executive-level overview of the point-of-care diagnostics market ... Read More
-
Lab Automation For In-vitro Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... forecast period. The rise in testing as a result of the pandemic can be attributed to the growth in in-vitro diagnostic adoption. The growth of the market is anticipated to be fueled by the creation ... Read More
-
Global Respiratory Infectious Disease Diagnostics Market - 2022-2029
... a CAGR of 1.8% during the forecast period (2022-2029). Respiratory infections are caused by virus, bacteria, and other microbes, which further infect the respiratory system including the lungs, throat, and airways. Spread of infections is ... Read More
-
Tuberculosis (TB) Diagnostics Market Forecasts to 2028 – Global Analysis by Product Types (Detection of Latent Infection, Cytokine Detection Assay, Diagnostic Laboratory Methods, Other Product Types), Test Type (Tuberculin skin tests, Interferon-gamma release assays (IGRAs), Smear microscopy, Other test types), Type (Sputum Smear Microscopy, Rapid Molecular Diagnostics, Other Types), End-user (Diagnostic Laboratories, Hospitals, Other end users), and By Geography
... Smear microscopy, Other test types), Type (Sputum Smear Microscopy, Rapid Molecular Diagnostics, Other Types), End-user (Diagnostic Laboratories, Hospitals, Other end users), and By Geography According to Stratistics MRC, the Global Tuberculosis (TB) Diagnostics Market is ... Read More
-
Global Infectious Disease In Vitro Diagnostics Market Size study & Forecast, by Product (Instruments, Reagents, Software), by Application (Respiratory Virus, TB and Drug-resistant TB, Gastro-intestinal Panel Testing, HIV, Hepatitis, COVID-19, Others), by Technology (Immunoassay, Molecular Diagnostics, Others, Microbiology) and Regional Analysis, 2022-2029
... Diagnostics, Others, Microbiology) and Regional Analysis, 2022-2029 Global Infectious Disease In Vitro Diagnostics Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more ... Read More
-
North America Immunodiagnostic Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product [Enzyme-Linked Immunosorbent Assays, Chemiluminescence Immunoassays (Vitamin D Assay, HIV Detection, HIV Ag/Ab Combo Assay, and Others), Radioimmunoassays, and Others], Clinical Indication [Infectious Diseases (COVID-19, Lyme, Zika, Infection Management, TORCH, Tuberculosis, Treponema, Measles & Mumps, EBV, and VZV), Hepatitis+HIV, Gastrointestinal, Metabolics[PL1] , Endocrinology (Hypertension, GROWTH, Diabetes, Thyroid, and Reproductive Endocrinology), and Others], and End User (Hospitals, Clinics, Diagnostic Laboratories, Academic & Research Institutes, and Others) [PL2]
... Clinical Indication [Infectious Diseases (COVID-19, Lyme, Zika, Infection Management, TORCH, Tuberculosis, Treponema, Measles & Mumps, EBV, and VZV), Hepatitis+HIV, Gastrointestinal, Metabolics[PL1] , Endocrinology (Hypertension, GROWTH, Diabetes, Thyroid, and Reproductive Endocrinology), and Others], and End User ... Read More
-
Hepatitis E Diagnostic Tests Market By Test Type (ELISA HEV IgM Test, ELISA HEV IgG Test, RT-PCR Test), By End User (Hospitals, Diagnostic Centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
... E diagnostic tests market was valued at $61.69 million in 2021, and is projected to reach $93.5 million by 2031, registering a CAGR of 4.2% from 2022 to 2031. Hepatitis E is a type of ... Read More
-
United States Market for In Vitro Diagnostic (IVD) Tests
... state of flux, trying to manage a myriad of issues, all of which collide with a huge system that costs more than any other in the world. This latest report from Kalorama Information, United States ... Read More
-
Global Hepatitis E Diagnostic Tests Market - 2022-2029
... a CAGR of 4.5 % during the forecast period (2022-2029). The hepatitis E virus causes the enteric liver disease known as hepatitis E. (HEV). It belongs to the group of five known human hepatitis viruses ... Read More
-
2022 Medical and Diagnostic Testing Global Market Size & Growth Report with Updated Forecasts
... with forecasts for 2022 and 2026. The historical data utilizes in-depth survey results from companies that sell medical and diagnostic testing combined with country and regional economic, firmographic, and demographic data. Our analysts develop the ... Read More
-
Veterinary Tuberculosis Vaccine Market, by Type (Live Attenuated, Inactivated), by Route of Administration (Sub-cutaneous, Intramuscular, Oral), by Animal Type (Cattle, Dogs, Cats, Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Tuberculosis (TB) is considered a reemerging, infectious granulomatous disease in animals and people caused by acid-fast bacilli of the genus Mycobacterium. Although commonly ... Read More
-
Point of Care Diagnostics Market Analysis and Forecast to 2031: By Product (Glucose Monitoring, Cardiometabolic Testing, Infectious Disease Testing, Blood Gas/Electrolytes Testing, Pregnancy & Fertility Testing, Tumor/Cancer Marker Testing), By Technology (Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays), By Application (Cardio Metabolic Testing, Infectious Disease Testing, Nephrology Testing, Drug-of-Abuse (DoA) Testing), By End-use (Hospitals, Diagnostic Centers, Research Laboratories, Home-Care Settings), and Region
... Microfluidics, Molecular Diagnostics, Immunoassays), By Application (Cardio Metabolic Testing, Infectious Disease Testing, Nephrology Testing, Drug-of-Abuse (DoA) Testing), By End-use (Hospitals, Diagnostic Centers, Research Laboratories, Home-Care Settings), and Region The global point of care diagnostics market ... Read More
-
Slide Stainer Market by Product (Reagent (Stains, Probes, ABS), Equipment (Automated, Manual)), Technology (H&E, IHC, ISH, Cytology), Application (Disease Diagnosis (Cancer) Research), End User (Hospitals, Diagnostic Labs) - Global Forecast to 2027
... stainer market is valued at USD 4.3 billion in 2022 and is projected to reach USD 5.9 billion in 2027 at a CAGR of 6.8% from 2022 to 2027. The major factors driving the growth ... Read More
-
Hepatitis C Testing Market By Technique (Immunoassay, PCR, Other techniques), By Test (Antibody test, Genotype tests, Viral load test), By End User (Hospital and diagnostic laboratory, Blood banks, Other end users): Global Opportunity Analysis and Industry Forecast, 2021-2031
... Industry Forecast, 2021-2031 The global hepatitis C testing market was valued at $1,329.0 million in 2021, and is projected to reach $2,248.2 million by 2031, registering a CAGR of 5.3% from 2022 to 2031. Hepatitis ... Read More
-
The Worldwide Market for In Vitro Diagnostic Tests, 15th Edition
... state of IVD and its future is a vital part of making well-informed decisions. The 15th edition of Kalorama’s Worldwide Market for In Vitro Diagnostic Tests provides readers with reliable estimates, real-world forecasts, and insights ... Read More
-
Emerging Infectious Disease Market Trends, 2022
... as possibilities for the next threat. The search is constant, and is by no means limited to respiratory epidemics. As the recent monkeypox concern has demonstrated, little-known pathogens can emerge and become large health threats. ... Read More
-
Global Latent Tuberculosis Infection (LTBI) Testing Market: Analysis By Type (Tuberculin Skin Test LTBI Testing and Interferon Gamma Released Assay (IGRA) LTBI Testing), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2027
... to 2027 The global latent tuberculosis infection (LTBI) testing market in 2021 was valued at US$1.75 billion. The market value is expected to reach US$2.47 billion by 2027. Latent Tuberculosis tests diagnose latent tuberculosis which ... Read More
-
Legionella Testing Market by Test Type (Culture, Urinary Antigen Test, DFA, PCR), Application (Water & IVD Testing (Urine, Blood)), End User (Hospitals, Clinics, Diagnostic Labs, Water Treatment Industries), Region - Global Forecast to 2027
... global legionella testing market is projected to reach USD 439 million by 2027 from USD 296 million in 2022, at a CAGR of 8.2% during the forecast period. Growth in this market is mainly driven ... Read More
-
Asia Pacific HIV Diagnostics Market, by Product Type (Instruments and Reagents & Kits), by Test Type (Screening {Third Generation and Fourth Generation}, Differentiation & Confirmation Test, and Monitoring Test {CD4 Tests and Viral Load Tests}), by End User (Hospitals and Clinics, Diagnostic Laboratories, Home Care Settings, and Others), and by Country (China, Japan, South Korea, ASEAN, India, Australia, and Rest of Asia Pacific) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... by End User (Hospitals and Clinics, Diagnostic Laboratories, Home Care Settings, and Others), and by Country (China, Japan, South Korea, ASEAN, India, Australia, and Rest of Asia Pacific) - Size, Share, Outlook, and Opportunity Analysis, ... Read More
-
Infectious Disease Diagnostics Market Analysis and Forecast to 2031: By Product & Service (Assays, Kits & Reagents, Instruments, Services & Software), Technology (Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next Generation Sequencing, DNA Microarray, Others), Diseases Type (Hepatitis, Human Immunodeficiency Virus, Chlamydia Trachomatis Genital Infection & Gonorrhea, Hospital Acquired Infections, Human Papillomavirus, Tuberculosis, Influenza, Others), End Use (Hospitals/Clinical Laboratories, Reference Laboratories, Others), and Region
... & Next Generation Sequencing, DNA Microarray, Others), Diseases Type (Hepatitis, Human Immunodeficiency Virus, Chlamydia Trachomatis Genital Infection & Gonorrhea, Hospital Acquired Infections, Human Papillomavirus, Tuberculosis, Influenza, Others), End Use (Hospitals/Clinical Laboratories, Reference Laboratories, Others), and ... Read More
-
Digital Pathology Market, by Offering (Scanner (Bright Field Scanner, Fluorescence Scanner), Software (Image Analysis Platform(On-Premises Delivery, Cloud Based Delivery), DPIS(On-Premises Delivery, Cloud Based Delivery), Services(Installation and Integration, Maintenance Services, Consulting Services)), by Application (Hematology, Chemical Pathology, Histopathology, Medical Microbiology), by End User (Hospitals, Laboratories (Private Laboratories, Public Laboratories, Research center ), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Pathology, Histopathology, Medical Microbiology), by End User (Hospitals, Laboratories (Private Laboratories, Public Laboratories, Research center ), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity ... Read More
Research Assistance
